Lei Pang

Lei Pang is currently the Director Biostatistics at Genmab, since August 2018. Previously, Lei worked as an Associate Principal Scientist at Merck from April 2012 to August 2018. Lei was involved in leading statistical support for various clinical trials and development programs related to Pembrolizumab in urothelial cancer and in combination with other medications. With a Ph.D. in Statistics from North Carolina State University, Lei has a strong background in biostatistics and has also worked as an Intern Biostatistician at Quintiles.